Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-3-23
pubmed:databankReference
pubmed:abstractText
The scaffold protein Ste5 is required to properly direct signaling through the yeast mating pathway to the mitogen-activated protein kinase (MAPK), Fus3. Scaffolds are thought to function by tethering kinase and substrate in proximity. We find, however, that the previously identified Fus3-binding site on Ste5 is not required for signaling, suggesting an alternative mechanism controls Fus3's activation by the MAPKK Ste7. Reconstituting MAPK signaling in vitro, we find that Fus3 is an intrinsically poor substrate for Ste7, although the related filamentation MAPK, Kss1, is an excellent substrate. We identify and structurally characterize a domain in Ste5 that catalytically unlocks Fus3 for phosphorylation by Ste7. This domain selectively increases the k(cat) of Ste7-->Fus3 phosphorylation but has no effect on Ste7-->Kss1 phosphorylation. The dual requirement for both Ste7 and this Ste5 domain in Fus3 activation explains why Fus3 is selectively activated by the mating pathway and not by other pathways that also utilize Ste7.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-10222191, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-10712921, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-11071925, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-11728304, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-11781566, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-11818078, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-11823456, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-11973128, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-12388743, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-12511654, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-15456892, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-15620356, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-15620357, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-15713635, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-15744308, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-16209942, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-16364919, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-16424299, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-16463042, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-17079133, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-17876813, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-17952059, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-18538663, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-19303841, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-7667635, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-8049522, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-8062390, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-8662544, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-8668180, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-9311911, http://linkedlifedata.com/resource/pubmed/commentcorrection/19303851-9335587
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1097-4172
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1085-97
pubmed:dateRevised
2010-12-3
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation.
pubmed:affiliation
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't